Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M268Revenue $M1.7Net Margin (%)--Altman Z-Score--
Enterprise Value $M224EPS $-1.2Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M28.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with BMTI

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BMTI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BMTI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pagano Russell P.VP, Reg. & Clinical Affairs 2013-01-22Sell1,381$8.1-100 view
Friedlaender Gary EDirector 2012-04-02Buy10,000$2.79-100 view
Lynch Samuel EugenePresident and CEO 2012-03-30Buy70,000$2.41-100 view
Pagano Russell P.VP, Reg. & Clinical Affairs 2012-03-29Sell3,438$2.36-100 view
Douglas Earl MartinGeneral Counsel 2012-03-28Sell53,561$2.35-100 view
PAPASAN LARRY WDirector 2012-03-27Buy10,400$2.32-100 view
Lynch Samuel EugenePresident and CEO 2012-03-23Buy13,150$2.35-100 view
BULLOCK LAWRENCE ECFO 2012-03-20Buy20,000$2.2-100 view
Friedlaender Gary EDirector 2012-03-19Buy15,000$2.19-100 view
Douglas Earl MartinGeneral Counsel 2011-10-14Sell9,000$3.01-100 view

Quarterly/Annual Reports about BMTI:

    News about BMTI:

    Articles On GuruFocus.com
    BioMimetic Therapeutics Up $24.28% on July 10 Jul 10 2012 
    Weekly CEO Buys Highlight: VRA, MTDR, BMTI, PZG, CAK Apr 10 2012 
    Insider purchases Apr 06 2012 
    Weekly CFO Buys Highlight: SSP, BMTI, POL, ANAC, CYTX Mar 26 2012 
    BioMimetic Therapeutics Inc. Reports Operating Results (10-K) Mar 10 2011 
    BioMimetic Therapeutics Inc. Reports Operating Results (10-Q) Nov 03 2010 
    BioMimetic Therapeutics Inc. Reports Operating Results (10-Q) Aug 05 2010 
    BioMimetic Therapeutics Inc. (BMTI) President and CEO Samuel Eugene Lynch sells 6,000 Shares Dec 30 2009 
    BioMimetic Therapeutics Inc. (BMTI) President and CEO Samuel Eugene Lynch sells 6,000 Shares Dec 16 2009 
    BioMimetic Therapeutics Inc. (BMTI) President and CEO Samuel Eugene Lynch sells 6,000 Shares Dec 04 2009 

    More From Other Websites
    No related articles found.

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GuruFocus Premium Plus Membership

    FEEDBACK